The authors showed that the GIC was independently associated with BADL and PPT after adjustment for the severity of individual diseases. Thus, the GIC seems to contain some information that is not obtained by using the number of diseases and their severity ratings only. In our review, we discussed the possibility that certain disease combinations may have synergistic effects, leading to more disability than would be expected on the basis of addition alone. Knowing these combinations would provide extra information, so it would be very interesting to study these phenomena in depth.
Although the GIC certainly seems promising, further validation studies are needed. We would be very interested in studies comparing the GIC with other comorbidity indices mentioned in our review and in more extensive reliability studies. However, on the basis of the information that is currently available, we would not be able to add the GIC to the list of recommended measures of comorbidity. The Netherlands
